- CNBC•2 days ago
Alere fell 3 percent after it sued Abbott to compel it to get all antitrust approvals required to complete its $5.8 billion merger.
- TheStreet.com•2 days ago
The provider of point-of-care testing has filed a suit in Delaware Chancery Court against Abbott in an effort to complete their pending deal. Meanwhile, St. Jude, gets a griping short-seller.
- American City Business Journals•2 days ago
Shares of Waltham-based diagnostics firm Alere fell 4 percent on Friday afternoon after the company issued a statement saying it’s suing the company it’s hoping to merge with, Abbott Laboratories. Illinois-based Abbott (ABT) announced an agreement to buy Alere on Feb. 1 for $5.8 billion, but the deal quickly ran into problems.
Alere Inc. (ALR)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||39.56 x 300|
|Ask||39.60 x 400|
|Day's Range||38.80 - 42.12|
|52wk Range||31.47 - 54.79|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-96.00|
|Avg Vol (3m)||1,028,366|
|Dividend & Yield||N/A (N/A)|